{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:21:16Z","timestamp":1774380076255,"version":"3.50.1"},"reference-count":56,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Cervical dystonia (CD), blepharospasm (BSP), and idiopathic hemifacial spasm (HFS) are focal hyperkinetic movement disorders with distinct underlying mechanisms. While CD and BSP involve central network dysfunctions within the basal ganglia-thalamo-cortical and cerebellar circuits, HFS primarily results from peripheral facial nerve hyperexcitability. Still, people living with all three conditions often struggle with mood issues like depression and anxiety, which can originate from both the burden of illness and changes in brain biology. We studied 61 patients (CD, n = 30; BSP, n = 9; HFS, n = 22) and assessed depression and anxiety before and three weeks after botulinum neurotoxin type A (BoNT-A) therapy, considering injection site and dose. BoNT-A significantly reduced depressive and anxiety symptoms across all groups, regardless of disease type, dose, or glabellar injection. These psychiatric improvements were not associated with the degree of motor symptom reduction, suggesting a partially independent mechanism of mood modulation. Our findings indicate that BoNT-A\u2019s mood benefits may extend beyond local motor effects, possibly involving broader sensorimotor-limbic interactions. These results highlight the therapeutic potential of BoNT-A for addressing non-motor symptoms in both dystonic and non-dystonic hyperkinetic disorders. Future studies employing imaging and neurophysiological methods are necessary to explain the neural pathways underlying these effects.<\/jats:p>","DOI":"10.3390\/toxins18020062","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T12:41:16Z","timestamp":1769431276000},"page":"62","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond Improvement of Motor Symptoms: Central Effects of Botulinum Toxin on Anxiety and Depression in Focal Dystonia, Hemifacial Spasm, and Blepharospasm"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7104-7322","authenticated-orcid":false,"given":"Tihana","family":"Gilman Kuric","sequence":"first","affiliation":[{"name":"Department of Neurology, Osijek University Hospital Center, 31000 Osijek, Croatia"},{"name":"Faculty of Medicine in Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3397-7726","authenticated-orcid":false,"given":"Zvonimir","family":"Popovic","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osijek University Hospital Center, 31000 Osijek, Croatia"},{"name":"Faculty of Medicine in Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6520-8254","authenticated-orcid":false,"given":"Sara","family":"Matosa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osijek University Hospital Center, 31000 Osijek, Croatia"},{"name":"Faculty of Medicine in Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Strujic","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osijek University Hospital Center, 31000 Osijek, Croatia"},{"name":"Faculty of Medicine in Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Gacic","sequence":"additional","affiliation":[{"name":"General Hospital \u201cDr. Josip Ben\u010devi\u0107\u201d Slavonski Brod, 35000 Slavonski Brod, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tea","family":"Mirosevic Zubonja","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osijek University Hospital Center, 31000 Osijek, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-1656","authenticated-orcid":false,"given":"Stjepan","family":"Juric","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osijek University Hospital Center, 31000 Osijek, Croatia"},{"name":"Faculty of Medicine in Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melita","family":"Pecek Prpic","sequence":"additional","affiliation":[{"name":"Osijek-Baranja County Health Centre, 31000 Osijek, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Jelusic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine in Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"},{"name":"Department of Ophthalmology and Optometry, Osijek University Hospital Center, 31000 Osijek, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-3534","authenticated-orcid":false,"given":"Dubravka","family":"Biuk","sequence":"additional","affiliation":[{"name":"Faculty of Medicine in Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"},{"name":"Department of Ophthalmology and Optometry, Osijek University Hospital Center, 31000 Osijek, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1613-3831","authenticated-orcid":false,"given":"Svetlana","family":"Tomic","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osijek University Hospital Center, 31000 Osijek, Croatia"},{"name":"Faculty of Medicine in Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: A consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sugar, D., and Pirio Richardson, S. (2025). Treating non-motor symptoms in dystonia: A systematic review. Dystonia, 4.","DOI":"10.3389\/dyst.2025.14545"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s11910-022-01233-3","article-title":"Cognitive and Neuropsychiatric Impairment in Dystonia","volume":"22","author":"Bailey","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5334\/tohm.466","article-title":"The Prevalence and Correlation of Non-motor Symptoms in Adult Patients with Idiopathic Focal or Segmental Dystonia","volume":"9","author":"Novaretti","year":"2019","journal-title":"Tremor Other Hyperkinetic Mov."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kuric, T., Popovi\u0107, Z., Matosa, S., Sadikov, A., Groznik, V., Georgiev, D., Gerbasi, A., Kragujevic, J., Zubonja, T.M., and Dupan, Z.K. (2024). Memory-Guided Saccades and Non-Motor Symptoms Improve after Botulinum Toxin Therapy in Cervical Dystonia. J. Clin. Med., 13.","DOI":"10.3390\/jcm13195708"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Guadagni, V., Burles, F., Callahan, B.L., Iaria, G., and Martino, D. (2025). Functional connectivity of brain areas related to social cognition and anxiety in cervical dystonia. Dystonia, 4.","DOI":"10.3389\/dyst.2025.14344"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wang, X., Hu, W., Wang, H., Gao, D., Liu, Y., Zhang, X., Jiang, Y., Mo, J., Meng, F., and Zhang, K. (2022). Altered Structural Brain Network Topology in Patients with Primary Craniocervical Dystonia. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.763305"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s00415-012-6510-x","article-title":"Botulinum toxin as treatment for focal dystonia: A systematic review of the pharmaco-therapeutic and pharmaco-economic value","volume":"259","author":"Zoons","year":"2012","journal-title":"J. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Weise, D., Weise, C.M., and Naumann, M. (2019). Central Effects of Botulinum Neurotoxin\u2014Evidence from Human Studies. Toxins, 11.","DOI":"10.3390\/toxins11010021"},{"key":"ref_10","first-page":"21","article-title":"Psychiatric symptoms in women with focal cervical dystonia\u2014Exploring new pathophysiological pathways","volume":"59","author":"Kuric","year":"2023","journal-title":"Arch. Psychiatry Res. Int. J. Psychiatry Relat. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","article-title":"Long-distance retrograde effects of botulinum neurotoxin A","volume":"28","author":"Antonucci","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Luvisetto, S. (2021). Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy. Toxins, 13.","DOI":"10.3390\/toxins13110751"},{"key":"ref_13","first-page":"75","article-title":"Botulinum Toxin A Therapy for Glabellar Lines Improves Emotional States: Evaluation of 47 Cases without Mental Disorders","volume":"4","author":"Hanayama","year":"2024","journal-title":"J. Plast. Reconstr. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101792","DOI":"10.1016\/j.nicl.2019.101792","article-title":"Cause or effect: Altered brain and network activity in cervical dystonia is partially normalized by botulinum toxin treatment","volume":"22","author":"Brodoehl","year":"2019","journal-title":"Neuroimage Clin."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1038\/s41598-023-29280-x","article-title":"Modulation of amygdala activity for emotional faces due to botulinum toxin type A injections that prevent frowning","volume":"13","author":"Stark","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105684","DOI":"10.1016\/j.neubiorev.2024.105684","article-title":"Sensorimotor regulation of facial expression\u2014An untouched frontier","volume":"162","author":"Bress","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wollmer, M.A., Magid, M., Kr\u00fcger, T.H.C., and Finzi, E. (2022). Treatment of Depression with Botulinum Toxin. Toxins, 14.","DOI":"10.3390\/toxins14060383"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.11.006","article-title":"Treatment of depression with onabotulinumtoxinA: A randomized, double-blind, placebo-controlled trial","volume":"52","author":"Finzi","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Xu, H., Guo, C., Li, H., Gao, L., Zhang, M., and Wang, Y. (2019). Structural and Functional Amygdala Abnormalities in Hemifacial Spasm. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.00393"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Gao, W., Yang, D., Zhang, Z., Du, L., Liu, B., Liu, J., Chen, Y., Wang, Y., Liu, X., and Yang, A. (2021). Altered cortical\u2013striatal network in patients with hemifacial spasm. Front. Hum. Neurosci., 15.","DOI":"10.3389\/fnhum.2021.770107"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1016\/j.wneu.2019.01.044","article-title":"Preliminary Study on the Relationship Between Inflammation and Hemifacial Spasm","volume":"125","author":"Chen","year":"2019","journal-title":"World Neurosurg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00221-018-5322-3","article-title":"Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: A functional MRI study","volume":"236","author":"Hok","year":"2018","journal-title":"Exp. Brain Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/cercor\/bhn104","article-title":"The link between facial feedback and neural activity within central circuitries of emotion\u2014New insights from botulinum toxin-induced denervation of frown muscles","volume":"19","author":"Hennenlotter","year":"2009","journal-title":"Cereb Cortex"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4088\/JCP.13m08845","article-title":"Treatment of major depres-sive disorder using botulinum toxin A: A 24-week randomized, double-blind, placebo-controlled study","volume":"75","author":"Magid","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00702-021-02299-y","article-title":"Contemporary functional neuroanatomy and pathophysiology of dystonia","volume":"128","year":"2021","journal-title":"J. Neural Transm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5334\/tohm.383","article-title":"The Anatomical Basis for Dystonia: The Motor Network Model","volume":"7","author":"Jinnah","year":"2017","journal-title":"Tremor Other Hyperkinetic Mov."},{"key":"ref_27","first-page":"e1499","article-title":"Focal Dystonia: Functional Connectivity Changes in Cerebellar-Basal Ganglia-Cortical Circuit and Preserved Global Functional Architecture","volume":"98","author":"Pasqua","year":"2022","journal-title":"Neurology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/mds.26930","article-title":"Disruption in cerebellar and basal ganglia networks during a visuospatial task in cervical dystonia","volume":"32","author":"Filip","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/brain\/awr224","article-title":"The non-motor syndrome of primary dystonia: Clinical and pathophysiological implications","volume":"135","author":"Stamelou","year":"2012","journal-title":"Brain"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4103\/aian.AIAN_27_20","article-title":"Non-Motor Symptoms in Cervical Dystonia: A Review","volume":"23","author":"Yadav","year":"2020","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/mds.23709","article-title":"Nonmotor manifestations of dystonia: A systematic review","volume":"26","author":"Kuyper","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/brain\/awab131","article-title":"The neuroimaging evidence of brain abnormalities in functional movement disorders","volume":"144","author":"Sasikumar","year":"2021","journal-title":"Brain"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9740","DOI":"10.1523\/JNEUROSCI.2300-09.2009","article-title":"Cerebellothalamocortical connectivity regulates penetrance in dystonia","volume":"29","author":"Argyelan","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00415-025-13220-y","article-title":"Hemifacial spasm: An update on pathophysiology, investigations and management","volume":"272","author":"Jesuthasan","year":"2025","journal-title":"J. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/365160a0","article-title":"Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25","volume":"365","author":"Blasi","year":"1993","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Hok, P., Veverka, T., Hlu\u0161t\u00edk, P., Nevrl\u00fd, M., and Ka\u0148ovsk\u00fd, P. (2021). The Central Effects of Botulinum Toxin in Dystonia and Spasticity. Toxins, 13.","DOI":"10.3390\/toxins13020155"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Antonucci, F., Corradini, I., Fossati, G., Tomasoni, R., Menna, E., and Matteoli, M. (2016). SNAP-25, a Known Presynaptic Protein with Emerging Postsynaptic Functions. Front. Synaptic. Neurosci., 8.","DOI":"10.3389\/fnsyn.2016.00007"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1038\/s41598-024-54906-z","article-title":"Botulinum toxin-A effects on pain, somatosensory and psychosocial features of patients with refractory masticatory myofascial pain: A randomized double-blind clinical trial","volume":"14","author":"Poluha","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00702-024-02785-z","article-title":"Does botulinum toxin affect psycho-social aspects in dystonia?","volume":"131","author":"Marfoli","year":"2024","journal-title":"J. Neural Transm."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Avanzino, L., and Fiorio, M. (2014). Proprioceptive dysfunction in focal dystonia: From experimental evidence to rehabilitation strategies. Front. Hum. Neurosci., 8.","DOI":"10.3389\/fnhum.2014.01000"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/mds.25532","article-title":"Emerging concepts in the physiological basis of dystonia","volume":"28","author":"Quartarone","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Restani, L., Giribaldi, F., Manich, M., Bercsenyi, K., Menendez, G., Rossetto, O., Caleo, M., and Schiavo, G. (2012). Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003087"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jpsychires.2021.01.016","article-title":"Botulinum toxin for the management of depression: An updated review of the evidence and meta-analysis","volume":"135","author":"Schulze","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Qian, H., Shao, F., Lenahan, C., Shao, A., and Li, Y. (2020). Efficacy and Safety of Botulinum Toxin vs. Placebo in Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.603087"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2045-5380-4-11","article-title":"Botulinum toxin-induced facial muscle paralysis affects amygdala responses to the perception of emotional expressions: Preliminary findings from an A-B-A design","volume":"4","author":"Kim","year":"2014","journal-title":"Biol. Mood Anxiety Disord"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Park, J., and Park, H.J. (2017). Botulinum Toxin for the Treatment of Neuropathic Pain. Toxins, 9.","DOI":"10.3390\/toxins9090260"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: From evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.280.2.147","article-title":"Persistent pain and well-being: A World Health Organization study in primary care","volume":"280","author":"Gureje","year":"1998","journal-title":"JAMA"},{"key":"ref_49","first-page":"445","article-title":"The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): Assessment of validity and inter-rater reliability","volume":"40","author":"Consky","year":"1990","journal-title":"Neurology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"328","author":"Tsui","year":"1986","journal-title":"Lancet"},{"key":"ref_51","unstructured":"Titi-Lartey, O.A., and Patel, B.C. (2025). Benign Essential Blepharospasm. StatPearls, StatPearls Publishing."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: Psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J. Consult. Clin. Psychol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","article-title":"EFNS guidelines on diagnosis and treatment of primary dystonias","volume":"18","author":"Albanese","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00702-007-0768-7","article-title":"Botulinum toxin in the treatment of blepharospasm and hemifacial spasm","volume":"115","author":"Kenney","year":"2008","journal-title":"J. Neural Transm."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/2\/62\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T12:53:25Z","timestamp":1769432005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/2\/62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["toxins18020062"],"URL":"https:\/\/doi.org\/10.3390\/toxins18020062","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]}}}